European Economics Preview: Germany Industrial Output Data Due

previewimage sept25 05aug22 lt

Industrial production from Germany and France are due on Friday, headlining a light day for the European economic news.

At 2.00 am ET, Destatis is scheduled to issue Germany's industrial production data for June. Output is forecast to fall 0.3 percent month-on-month, reversing a 0.2 percent rise in May.

In the meantime, UK Halifax house price data is due. Economists expect house prices to grow 1.2 percent month-on-month in July, slower than the 1.8 percent increase in June.

At 2.45 am ET, France's industrial production, current account and foreign trade figures are due. Production is seen falling by 0.2 percent on month in June after staying flat in May.

At 3.00 am ET, industrial production from Spain and Hungary and retail sales from the Czech Republic are due.

At 4.00 am ET, Italy's Istat publishes industrial output figures for June. Economists forecast output to fall 0.2 percent in June from May, when production declined 1.1 percent.

At 8.00 am ET, Romania's central bank announces its monetary policy decision. The bank is set to hike its key rate to 5.75 percent from 4.75 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT